ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,997,000 | +15.5% | 1,218,851 | +0.6% | 0.20% | +29.2% |
| Q4 2021 | $4,325,000 | +75.6% | 1,211,351 | +79.0% | 0.15% | +69.2% |
| Q3 2021 | $2,463,000 | -16.8% | 676,687 | -0.3% | 0.09% | -13.3% |
| Q2 2021 | $2,959,000 | +2.6% | 678,683 | -3.3% | 0.10% | +11.7% |
| Q1 2021 | $2,883,000 | +20.5% | 701,499 | +17.0% | 0.09% | +11.9% |
| Q4 2020 | $2,393,000 | – | 599,628 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |